Advanced Enzyme Technologies Ltd logo

Advanced Enzyme Technologies Ltd

ADVENZYMES NSE

Key Fundamentals

MicrocapBiotechnologyHealthcare
Market Cap
₹4,121 Cr
Volatility
Moderate
P/E Ratio
24.47
EBITDA
₹229 Cr
Return on Equity
9.99%
Debt to Equity
0.03
Book Value
₹145.74
EPS
₹13.3
52W High
₹419
52W Low
₹251.95

Technical Indicators

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 32.0%

Weaknesses

5
  • Stock is trading at 2.53 times its book value
  • The company has delivered a poor sales growth of 8.24% over past five years.
  • Company has a low return on equity of 10.4% over last 3 years.
  • Promoter holding has decreased over last 3 years: -6.61%
  • Working capital days have increased from 205 days to 402 days

Growth Rate

Revenue Growth
11.31% ↗
Net Income Growth
31.41% ↗
Cash Flow Change
0.80% ↗
ROE
-8.71% ↘
ROCE
-6.22% ↘
EBITDA Margin (Avg.)
-14.82% ↘

Quarterly Results

  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
139
147
158
161
158
155
146
169
167
186
185
172
203
Expenses
95
103
107
107
102
103
104
114
122
129
124
123
140
Operating Profit
44
44
51
54
55
51
42
55
46
56
60
49
63
OPM %
32%
30%
32%
33%
35%
33%
29%
33%
27%
30%
33%
29%
31%
Other Income
7
7
6
14
-6
7
10
8
9
9
10
20
7
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
Depreciation
8
9
9
9
9
9
9
9
10
10
10
10
10
PBT
42
41
48
59
40
49
42
53
43
55
60
58
60
Tax %
24%
29%
27%
28%
25%
28%
21%
27%
38%
26%
25%
26%
24%
Net Profit
32
29
35
42
30
35
33
39
27
40
45
43
45
EPS in Rs
2.87
2.58
3.08
3.74
2.53
3.05
2.94
3.37
2.37
3.57
3.87
3.8
3.84
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
222
293
329
391
420
444
502
529
541
624
637
746
Expenses
131
155
177
226
236
241
269
327
382
418
441
517
Operating Profit
91
138
152
165
184
203
232
203
158
206
196
229
OPM %
41%
47%
46%
42%
44%
46%
46%
38%
29%
33%
31%
31%
Other Income
1
-3
3
1
5
6
9
6
21
21
33
46
Interest
9
8
4
9
5
4
3
3
3
4
5
3
Depreciation
9
9
13
18
21
26
28
35
35
35
37
40
PBT
74
118
137
139
162
179
210
171
140
188
187
233
Tax %
31%
35%
32%
33%
28%
26%
28%
28%
26%
27%
28%
25%
Net Profit
51
77
93
94
116
133
151
124
104
137
134
174
EPS in Rs
4.6
6.97
8.2
8.07
9.95
11.58
13.09
10.7
9.45
11.92
11.72
15.07
Div. Payout %
4%
3%
5%
6%
6%
5%
7%
9%
11%
43%
44%
9%
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
22
22
22
22
22
22
22
22
22
22
22
22
Reserves
188
256
442
537
657
817
948
1,066
1,213
1,302
1,398
1,610
Borrowings
115
101
54
67
35
28
23
35
34
47
39
32
Other Liabilities
92
71
65
102
91
104
153
137
142
150
151
175
Total Liabilities
417
450
583
727
805
971
1,146
1,260
1,411
1,521
1,611
1,839
Fixed Assets
287
285
421
491
495
563
601
619
649
650
679
692
CWIP
5
7
8
11
10
10
10
15
22
41
22
51
Investments
0
0
0
0
111
124
121
102
360
403
480
584
Other Assets
125
158
153
226
188
275
413
524
380
427
430
511
Total Assets
417
450
583
727
805
971
1,146
1,260
1,411
1,521
1,611
1,839
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
54
93
107
116
129
141
163
122
140
141
142
157
Investing
-15
-10
-60
-60
-124
-43
-27
2
-286
-65
-89
-74
Financing
-36
-63
-65
-2
-43
-39
-26
-48
-26
-59
-73
-70
Net Cash Flow
2
21
-18
54
-38
60
109
75
-171
17
-20
12
Free Cash Flow
42
88
97
105
116
90
143
95
102
94
108
105
CFO/OP
88
88
105
97
70
69
94
87
112
93
103
97
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
61
52
55
55
51
61
63
61
68
58
66
71
Inventory Days
403
358
352
339
363
361
346
402
343
375
378
335
Days Payable
89
68
57
78
46
43
56
60
67
40
41
76
Cash Conversion Cycle
374
342
351
315
369
379
353
404
344
393
403
331
Working Capital Days
-43
3
76
47
72
90
94
116
109
102
112
402
ROCE %
25%
36%
31%
25%
24%
22%
22%
16%
12%
15%
13%
14%

Shareholding Pattern

As of Mar 2026
Promoters 43.26%
FIIs 25.49%
Public 17.57%
Others 8.26%
DIIs 5.41%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters
55.38%
52.30%
52.55%
52.71%
52.70%
52.70%
49.87%
49.87%
49.87%
46.52%
45.92%
43.62%
43.49%
43.02%
42.95%
42.93%
43.08%
43.08%
43.07%
43.04%
43.26%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
23.01%
12.03%
12.63%
12.58%
11.90%
23.46%
25.41%
25.86%
25.49%
DIIs
7.29%
8.23%
8.32%
8.50%
6.46%
6.05%
5.36%
5.64%
5.73%
7.59%
5.84%
5.42%
7.56%
8.08%
8.02%
8.18%
8.19%
8.45%
6.41%
5.51%
5.41%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
13.51%
14.31%
15.31%
14.87%
15.21%
15.14%
13.37%
13.43%
13.28%
14.23%
15.28%
15.90%
15.43%
16.42%
16.04%
16.11%
16.68%
16.92%
16.95%
17.44%
17.57%
Others
23.82%
25.16%
23.83%
23.92%
25.63%
26.12%
31.40%
31.06%
31.11%
31.66%
32.97%
35.06%
10.51%
20.45%
20.36%
20.21%
20.16%
8.10%
8.15%
8.15%
8.26%
No. of Shareholders
0
62,388
79,254
87,112
84,346
86,573
84,376
84,277
77,537
75,052
72,642
73,034
68,640
65,222
66,758
67,351
65,322
67,589
69,637
68,051
66,193

Documents

Frequently Asked Questions about Advanced Enzyme Technologies Ltd

What does Advanced Enzyme Technologies Ltd do?
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]
Where is Advanced Enzyme Technologies Ltd (ADVENZYMES) listed?
Advanced Enzyme Technologies Ltd is listed on the Indian stock exchanges. It is listed on NSE: ADVENZYMES and BSE: 540025. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Advanced Enzyme Technologies Ltd belong to?
Advanced Enzyme Technologies Ltd operates in the Healthcare sector within the Pharmaceuticals & Biotechnology industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Advanced Enzyme Technologies Ltd?
Advanced Enzyme Technologies Ltd has a market capitalisation of approximately ₹4121.14 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Advanced Enzyme Technologies Ltd?
The Price-to-Earnings (PE) ratio of Advanced Enzyme Technologies Ltd is 24.47. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Advanced Enzyme Technologies Ltd?
Over the past 52 weeks, Advanced Enzyme Technologies Ltd has traded between a low of ₹251.95 and a high of ₹419. This range helps investors understand the stock's price volatility and recent trading levels.
Does Advanced Enzyme Technologies Ltd pay dividends?
Yes, Advanced Enzyme Technologies Ltd has a dividend yield of 1.11%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Advanced Enzyme Technologies Ltd?
Advanced Enzyme Technologies Ltd has a Return on Equity (ROE) of 9.99%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Advanced Enzyme Technologies Ltd on Tapetide?
On Tapetide, you can view Advanced Enzyme Technologies Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]

Website advancedenzymes.com
CEO Mr. Beni Prasad Rauka CA
Employees 338
Listed 2016-08-01
Face Value ₹ 2
Issued Size 11,19,26,800